Barclays PLC Aclaris Therapeutics, Inc. Transaction History

Barclays PLC

  • $854 Billion
  • Q3 2025

A detailed history of Barclays PLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Barclays PLC holds 123,425 shares of ACRS stock, worth $311,031. This represents 0.0% of its overall portfolio holdings.

Number of Shares
123,425
Previous 156,337 21.05%
Holding current value
$311,031
Previous $222,000 5.41%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$1.41 - $2.13 $46,405 - $70,102
-32,912 Reduced 21.05%
123,425 $234,000
Q2 2025

Aug 13, 2025
BUY
$1.08 - $1.63 $40,322 - $60,857
37,336 Added 31.37%
156,337 $222,000
Q1 2025

May 15, 2025
BUY
$1.53 - $2.6 $158,814 - $269,880
103,800 Added 682.85%
119,001 $182,000
Q4 2024

Feb 13, 2025
SELL
$1.15 - $4.59 $5,970 - $23,831
-5,192 Reduced 25.46%
15,201 $38,000
Q3 2024

Nov 15, 2024
SELL
$1.12 - $1.4 $22,234 - $27,792
-19,852 Reduced 49.33%
20,393 $23,000
Q2 2024

Aug 14, 2024
SELL
$1.01 - $1.36 $28,301 - $38,108
-28,021 Reduced 41.05%
40,245 $44,000
Q1 2024

May 15, 2024
SELL
$0.92 - $1.44 $99,040 - $155,020
-107,653 Reduced 61.19%
68,266 $85,000
Q4 2023

Feb 15, 2024
SELL
$0.64 - $6.49 $37,267 - $377,919
-58,231 Reduced 24.87%
175,919 $184,000
Q3 2023

Nov 07, 2023
BUY
$6.56 - $10.95 $975,872 - $1.63 Million
148,761 Added 174.22%
234,150 $1.6 Million
Q2 2023

Aug 03, 2023
SELL
$7.89 - $10.64 $26,044 - $35,122
-3,301 Reduced 3.72%
85,389 $885,000
Q1 2023

May 04, 2023
BUY
$7.07 - $17.95 $324,371 - $823,546
45,880 Added 107.17%
88,690 $717,000
Q4 2022

Feb 13, 2023
BUY
$14.33 - $18.37 $374,055 - $479,512
26,103 Added 156.24%
42,810 $674,000
Q3 2022

Nov 03, 2022
SELL
$13.07 - $18.22 $68,774 - $95,873
-5,262 Reduced 23.95%
16,707 $263,000
Q2 2022

Aug 12, 2022
SELL
$10.16 - $17.08 $388,995 - $653,941
-38,287 Reduced 63.54%
21,969 $307,000
Q1 2022

May 16, 2022
SELL
$9.74 - $17.92 $392,151 - $721,495
-40,262 Reduced 40.05%
60,256 $1.04 Million
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.49 $617,782 - $930,953
50,349 Added 100.36%
100,518 $1.46 Million
Q3 2021

Nov 09, 2021
BUY
$13.38 - $18.8 $513,818 - $721,957
38,402 Added 326.35%
50,169 $903,000
Q2 2021

Aug 13, 2021
BUY
$17.08 - $29.6 $200,672 - $347,770
11,749 Added 65272.22%
11,767 $205,000
Q3 2020

Nov 12, 2020
SELL
$1.5 - $2.71 $12,414 - $22,427
-8,276 Reduced 99.78%
18 $0
Q2 2020

Aug 12, 2020
SELL
$1.04 - $1.73 $2,310 - $3,844
-2,222 Reduced 21.13%
8,294 $13,000
Q1 2020

May 13, 2020
SELL
$0.75 - $2.18 $55,002 - $159,874
-73,337 Reduced 87.46%
10,516 $11,000
Q4 2019

Feb 10, 2020
BUY
$1.02 - $1.97 $68,069 - $131,467
66,735 Added 389.85%
83,853 $159,000
Q3 2019

Nov 14, 2019
SELL
$0.79 - $2.47 $4,658 - $14,565
-5,897 Reduced 25.62%
17,118 $18,000
Q2 2019

Aug 14, 2019
BUY
$2.13 - $7.06 $26,693 - $88,475
12,532 Added 119.55%
23,015 $50,000
Q1 2019

May 15, 2019
BUY
$5.63 - $7.84 $59,019 - $82,186
10,483 New
10,483 $63,000
Q4 2018

Feb 14, 2019
SELL
$6.3 - $15.4 $77,130 - $188,542
-12,243 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$14.38 - $20.89 $147,812 - $214,728
10,279 Added 523.37%
12,243 $178,000
Q2 2018

Aug 14, 2018
SELL
$16.46 - $20.33 $72,654 - $89,736
-4,414 Reduced 69.21%
1,964 $39,000
Q1 2018

May 15, 2018
BUY
$17.08 - $25.64 $31,529 - $47,331
1,846 Added 40.73%
6,378 $111,000
Q4 2017

Feb 14, 2018
SELL
$21.47 - $27.8 $62,799 - $81,315
-2,925 Reduced 39.22%
4,532 $112,000
Q3 2017

Nov 14, 2017
BUY
$23.02 - $28.8 $171,660 - $214,761
7,457
7,457 $192,000

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $168M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email